Vanda Pharmaceuticals Inc expected to post a loss of 11 cents a share - Earnings Preview

Vanda Pharmaceuticals

11/02/2025 21:33

* Vanda Pharmaceuticals Inc  VNDA.OQ   VNDA.O  is expected
to show
a rise in quarterly revenue when it reports  results on February
13 for the period ending December 31 2024
    * The Washington Washington Dc-based  company is expected to
report a 15.4% increase in revenue to $52.248 million from
$45.27 million a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Vanda Pharmaceuticals
Inc is
for a loss of 11 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vanda
Pharmaceuticals Inc is $9.25​, above​ its last closing price
of $4.62. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -0.16       -0.16      -0.09     Beat    44.9
 Jun. 30 2024  -0.21       -0.21      -0.08     Beat    61.9
                                      -0.07             ​
 Dec. 31 2023  -0.09       -0.09      -0.04     Beat    55.6
 ​​Sep.        -0.04       -0.04      0.00      Beat    100
 30 2023                                                
 Jun. 30 2023  -0.13       -0.13      0.03      Beat    123.1​
 Dec. 31 2022  0.08        0.08       0.12      Beat    50
 This summary was machine generated February 11 at 21:33 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)